Cargando…

Quality of patient decision aids to support the public making COVID-19 decisions: An online environmental scan

OBJECTIVE: To identify and appraise the quality of COVID-19 patient decision aids (PtDAs). METHODS: We conducted an environmental scan of online publicly available COVID-19 PtDAs. Two reviewers independently searched and extracted data. We calculated median International Patient Decision Aid Standar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiss, Alda, Zhang, Qian, Carley, Meg, Smith, Maureen, Légaré, France, Archambault, Patrick, Stacey, Dawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197540/
https://www.ncbi.nlm.nih.gov/pubmed/37244134
http://dx.doi.org/10.1016/j.pec.2023.107797
Descripción
Sumario:OBJECTIVE: To identify and appraise the quality of COVID-19 patient decision aids (PtDAs). METHODS: We conducted an environmental scan of online publicly available COVID-19 PtDAs. Two reviewers independently searched and extracted data. We calculated median International Patient Decision Aid Standards (IPDAS) scores and proportion scoring > 70% on Patient Education Materials Information Tool (PEMAT) adequate for understandability and actionability. RESULTS: Of 876 resources identified, 12 were PtDAs. Decisions focused on initial COVID-19 vaccination series (n = 9), location of care for elderly (n = 2), and social distancing (n = 1). All 12 PtDAs were written materials and two had accompanying videos. The median IPDAS score minimizing risk of biased decisions was 4 of 6 items (IQR 1, range 2–4). For PEMAT, 92% had adequate for understandability and none for actionability. CONCLUSIONS: We identified few online publicly available COVID-19 PtDAs and none were about COVID-19 vaccination boosters or treatment. PtDAs scored poorly on actionability and none met all IPDAS criteria for minimizing risk of biased decisions. PRACTICE IMPLICATIONS: PtDA developers for COVID-19 and future pandemics should ensure their PtDAs meet all IPDAS criteria for minimizing risk of bias, have adequate scores for actionability, and are disseminated in the A to Z inventory.